Literature DB >> 2821400

Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.

S L Naylor1, B E Johnson, J D Minna, A Y Sakaguchi.   

Abstract

Specific chromosomal deletions sometimes associated with tumours such as retinoblastoma (chromosome 13q14) and Wilm's tumour (chromosome 11p13) have led to the hypothesis that recessive genes may be involved in tumorigenesis. This hypothesis is supported by demonstration of allele loss specific for these regions using polymorphic DNA markers and by the isolation of a complementary DNA clone for the retinoblastoma gene. A cytogenetic deletion in chromosome 3 (p14-p23) was reported in small-cell lung cancer (SCLC) by Whang-Peng et al. At least one homologue of chromosome 3 was affected in the majority of SCLC tumours; however, the multiple chromosomal changes seen presented the possibility that chromosome 3 was rearranged, not deleted. We used polymorphic DNA probes for chromosome 3p and compared tumour and constitutional genotypes of nine SCLC patients. Our data show loss of alleles of chromosome 3p markers in tumour DNA of all nine patients supporting the hypothesis that this region contributes to tumorigenesis in SCLC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821400     DOI: 10.1038/329451a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  91 in total

1.  Tumor suppressors on 3p: a neoclassic quartet.

Authors:  K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 2.  Molecular genetic abnormalities in the pathogenesis of human lung cancer.

Authors:  E Forgacs; S Zöchbauer-Müller; E Oláh; J D Minna
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  Quantitative fluorescence in situ hybridization in lung cancer as a diagnostic marker.

Authors:  K Truong; M Gerbault-Seureau; M N Guilly; P Vielh; G Zalcman; A Livartowski; A Chapelier; M F Poupon; B Dutrillaux; B Malfoy
Journal:  J Mol Diagn       Date:  1999-11       Impact factor: 5.568

4.  Linkage analysis of the Gi alpha 2 gene on mouse chromosome 9.

Authors:  J De Maeyer-Guignard; E De Maeyer
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

5.  Construction of a human chromosome 3 specific NotI linking library using a novel cloning procedure.

Authors:  E R Zabarovsky; F Boldog; T Thompson; D Scanlon; G Winberg; Z Marcsek; R Erlandsson; E J Stanbridge; G Klein; J Sümegi
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

6.  Localization of the human HF.10 finger gene on a chromosome region (3p21-22) frequently deleted in human cancers.

Authors:  E Donti; L Lanfrancone; K Huebner; A Pascucci; G Venti; G Pengue; F Grignani; C M Croce; L Lania; P G Pelicci
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

7.  Loss of heterozygosity on chromosome 1q in human breast cancer.

Authors:  L C Chen; C Dollbaum; H S Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.

Authors:  Cleo E Rolle; Rajani Kanteti; Mosmi Surati; Suvobroto Nandi; Immanuel Dhanasingh; Soheil Yala; Maria Tretiakova; Qudsia Arif; Todd Hembrough; Toni M Brand; Deric L Wheeler; Aliya N Husain; Everett E Vokes; Ajit Bharti; Ravi Salgia
Journal:  Mol Cancer Ther       Date:  2013-12-10       Impact factor: 6.261

Review 9.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

10.  Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo.

Authors:  K Maruno; A Absood; S I Said
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.